Price
Financials
Standalone, Rs crore| Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|
| Sales | 33.88 | 25.32 | 41.64 |
| Expenses | 25.53 | 25.55 | 31.22 |
| Operating Profit | 8.35 | -0.23 | 10.42 |
| OPM % | 24.65% | -0.91% | 25.02% |
| Other Income | 0.11 | 0.30 | 0.63 |
| Interest | 0.91 | 1.04 | 0.76 |
| Depreciation | 0.07 | 0.05 | 0.08 |
| Profit before tax | 7.48 | -1.02 | 10.21 |
| Tax % | 25.53% | -23.53% | 27.33% |
| Net Profit | 5.57 | -0.78 | 7.42 |
| EPS in Rs | 5.34 | -0.55 | 5.24 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 22.89 | 12.44 | 19.47 | 32.78 | 46.11 | 61.58 | 66.96 |
| Expenses | 20.01 | 11.54 | 17.07 | 29.25 | 41.11 | 51.81 | 56.64 |
| Operating Profit | 2.88 | 0.90 | 2.40 | 3.53 | 5.00 | 9.77 | 10.32 |
| OPM % | 12.58% | 7.23% | 12.33% | 10.77% | 10.84% | 15.87% | 15.41% |
| Other Income | 0.12 | 0.12 | 0.04 | 0.09 | 0.16 | 0.18 | 0.80 |
| Interest | 0.46 | 0.23 | 0.21 | 0.43 | 1.14 | 1.71 | 1.80 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.09 | 0.14 | 0.12 | 0.13 |
| Profit before tax | 2.50 | 0.76 | 2.21 | 3.10 | 3.88 | 8.12 | 9.19 |
| Tax % | 26.80% | 28.95% | 26.24% | 30.65% | 26.29% | 25.62% | 27.86% |
| Net Profit | 1.83 | 0.54 | 1.62 | 2.15 | 2.87 | 6.03 | 6.64 |
| EPS in Rs | 183.00 | 54.00 | 23.14 | 30.71 | 41.00 | 5.79 | 4.69 |
| Dividend Payout % | 0.00% | 0.00% | 34.57% | 24.42% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 40% | 27% | 9% | ||
| Compounded Profit Growth | % | 65% | 46% | 10% | ||
| Stock Price CAGR | % | % | % | -21% | ||
| Return on Equity | % | 23% | 23% | 17% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.70 | 0.70 | 0.70 | 10.42 | 14.17 |
| Reserves | 6.75 | 7.30 | 7.33 | 8.96 | 11.84 | 12.84 | 40.38 |
| Borrowings | 5.88 | 3.88 | 3.82 | 5.87 | 15.05 | 22.74 | 18.53 |
| Other Liabilities | 3.56 | 3.03 | 6.15 | 7.70 | 6.42 | 8.16 | 6.34 |
| Total Liabilities | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.16 | 79.42 |
| Fixed Assets | 0.06 | 0.04 | 0.20 | 0.36 | 0.28 | 0.24 | 0.29 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 |
| Investments | 0.47 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 15.76 | 14.16 | 17.80 | 22.87 | 33.73 | 53.92 | 78.73 |
| Total Assets | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.16 | 79.42 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.38 | 4.31 | 0.48 | -2.93 | -8.04 | -5.41 | -8.36 |
| Cash from Investing Activity | 0.10 | 0.37 | -0.23 | -0.32 | -0.04 | -0.05 | 0.05 |
| Cash from Financing Activity | 0.28 | -2.00 | -0.81 | 1.17 | 8.19 | 10.71 | 18.80 |
| Net Cash Flow | 0.00 | 2.68 | -0.55 | -2.08 | 0.11 | 5.25 | 10.48 |
| Free Cash Flow | -0.40 | 4.30 | 0.29 | -3.19 | -8.09 | -5.49 | -8.94 |
| CFO/OP | 10% | 503% | 47% | -54% | -136% | -35% | -59% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 117.84 | 135.85 | 104.42 | 113.91 | 128.71 | 165.96 | 202.94 |
| Inventory Days | 234.33 | 366.16 | 281.70 | 273.75 | 247.29 | 202.47 | 255.63 |
| Days Payable | 28.20 | 98.96 | 65.19 | 61.56 | 31.74 | 48.84 | 24.33 |
| Cash Conversion Cycle | 323.97 | 403.05 | 320.92 | 326.10 | 344.26 | 319.59 | 434.24 |
| Working Capital Days | 189.44 | 238.25 | 105.17 | 101.55 | 93.96 | 96.79 | 198.91 |
| ROCE % | 8.25% | 20.93% | 25.79% | 23.28% | 26.72% | 18.46% |
| Jun 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|
| Promoters | 67.01% | 67.01% | 67.05% |
| FIIs | 1.87% | 0.50% | 0.00% |
| DIIs | 12.33% | 10.73% | 11.17% |
| Public | 18.79% | 21.77% | 21.78% |
| No. of Shareholders | 920 | 603 | 550 |
Fundamentals
Market Cap₹ 95.0 Cr.
Current Price₹ 67.0
Stock P/E14.3
Book Value₹ 38.5
ROCE18.5 %
ROE17.1 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)9%
Compounded Profit Growth (TTM)10%
Standalone figures.
Valuation
Market capRs 92 Cr
Enterprise valueRs 98 Cr
P/E (TTM)42.85x
Price to book9.54x
Price to sales2.81x
EV / EBITDA27.02x
EV / EBIT27.71x
EV / sales2.98x
Earnings yield2.33%
Dividend yield0.56%
Profitability
Operating margin (excl. other income)10.77%
Operating margin (incl. other income)11.04%
EBITDA margin11.04%
Pre-tax margin9.46%
Net profit margin6.56%
ROE24.31%
ROCE25.79%
ROA10.43%
ROE, 3-year average17.63%
ROCE, 3-year average18.32%
ROA, 3-year average8.00%
ROIC (approx.)15.96%
Tax rate30.65%
Other income / net worth0.93%
Growth
Sales growth (latest year)68.36%
Profit growth (latest year)32.72%
Sales CAGR, 3 years12.72%
Profit CAGR, 3 years5.52%
Per share
EPS (TTM)Rs 1.52
EPS (latest year)Rs 30.71
EPS, 3-year averageRs 35.95
Book value per shareRs 6.82
Sales per shareRs 23.13
Cash flow per shareRs -2.07
Free cash flow per shareRs -6.31
Dividend per share (latest year)Rs 7.43
Dividend per share, 3-year averageRs 7.71
Dividends
Dividend payout24.19%
Dividend payout, 3-year average29.38%
Efficiency
Asset turnover1.41x
Fixed asset turnover91.06x
Inventory turnover1.34x
Inventory days272 days
Debtor days114 days
Debtors turnover3.20x
Creditor days24 days
Cash conversion cycle434 days
Working capital days199 days
Leverage
Total debtRs 6 Cr
Cash and bankRs 0 Cr
Net debtRs 6 Cr
Debt to equity0.61x
Net debt / EBITDA1.57x
Interest coverage8.21x
Owners' fund to total sources41.58%
Debt to assets25.27%
Cash flow
Cash from Operating Activity (latest year)Rs -3 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 1 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs -9 Cr
FCFE (approx.: FCF + change in debt)Rs -7 Cr
Cash from ops / profit, 5 years-1.26x
Statement figures
Net sales (TTM)Rs 33 Cr
Net sales (latest year)Rs 33 Cr
Operating profit excl. other income (latest year)Rs 4 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 4 Cr
PBDT (TTM)Rs 3 Cr
Profit before tax (TTM)Rs 3 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 15 Cr
Total expenditure (latest year)Rs 29 Cr
Total income (latest year)Rs 33 Cr
Share capitalRs 1 Cr
ReservesRs 9 Cr
Shareholders' fundsRs 10 Cr
Total assetsRs 23 Cr
Net blockRs 0 Cr
ReceivablesRs 10 Cr
InventoryRs 11 Cr
Other liabilitiesRs 8 Cr
Shares outstanding (crore)1.42
Ownership
Promoter holding67.05%
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | AAKAAR | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -4.6% | -2.8% | -1.8 pts |
| 1 month | -1.5% | -6.8% | +5.3 pts |
| 3 months | -8.4% | -7.6% | -0.8 pts |
| 6 months | +11.9% | +0.4% | +11.5 pts |
| 1 year | -31.3% | -9.9% | -21.4 pts |
Red flags
F-score 4 of 8| explain | Weak cash conversion Cash from operations was 43% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 22% of total assets in 2026 |
| explain | Share dilution Share count up 0% in a year, 600% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Godrej Consumer Products Ltd | 87,493 | 42.1 | 18.8 % |
| Dabur India Ltd | 67,481 | 34.0 | 20.3 % |
| Colgate-Palmolive (India) Ltd | 48,552 | 35.5 | 108 % |
| Cupid Ltd | 38,726 | 282 | 33.9 % |
| Gillette India Ltd | 22,694 | 34.0 | 90.7 % |
| Procter & Gamble Hygiene and Health Care Ltd | 22,305 | 28.2 | 157 % |
| Emami Ltd | 16,633 | 22.0 | 28.1 % |
| Honasa Consumer Ltd | 14,399 | 57.0 | 19.2 % |
| Bajaj Consumer Care Ltd | 6,439 | 28.9 | 30.0 % |
| Anondita Medicare Ltd | 2,085 | 62.3 | 43.8 % |
| Recode Studios Ltd | 454 | 40.5 | 74.1 % |
| Radix Industries (India) Ltd | 203 | 69.2 | 19.6 % |
| Macobs Technologies Ltd | 189 | 65.3 | 11.0 % |
| H. R. Hygiene Products Ltd | 156 | 13.7 | 30.4 % |
| Thrive Future Habitats Limited | 100 | -7.67 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysSME scrip is not regularly traded
Quick answers
What is the market cap of Aakaar Medical Technologies Ltd?
Aakaar Medical Technologies Ltd (AAKAAR) has a market capitalisation of Rs 95.0 Cr. at the 2026-10-01 close.
What is the P/E ratio of Aakaar Medical Technologies Ltd?
Aakaar Medical Technologies Ltd trades at a P/E of 14.3 on trailing twelve-month profit, at the 2026-10-01 close.
What is the 52-week high and low of Aakaar Medical Technologies Ltd?
The 52-week high is Rs 90.00 and the 52-week low is Rs 46.00.